Relationship Between Hypothyroidism, Risk of Small Intestinal Bacterial Overgrowth, and Duodenal Microbiome Alterations.
Margaret Wei, Sepideh Mehravar, Gabriela Leite, Parnian Naji, Gillian M Barlow, Ava Hosseini, Mohamad Rashid, Maritza Sanchez, Cristina M Fajardo, Mark Pimentel, Ruchi Mathur
The Journal of clinical endocrinology and metabolism
40908532
February 20, 2026
Quality Indicators
Abstract Only: Full text of this study is not publicly available. This summary is based on the abstract only and may be less detailed than usual.
AI-Generated Summary: This summary was created by AI and may contain errors. Always consult healthcare professionals and read the original study for medical decisions.
Study Summary
AI-generated overview of this research
Quick Summary
This study examined whether people with hypothyroidism (underactive thyroid) have higher rates of SIBO and different bacteria in their small intestine. Researchers found that hypothyroid patients were 2.2 times more likely to develop SIBO over 10 years, but taking levothyroxine (thyroid replacement medication) appeared to reduce this risk. The bacterial makeup in the small intestine differed between hypothyroid and non-hypothyroid patients, particularly in which types of Gram-negative bacteria were present.
What Was Studied
Researchers investigated whether hypothyroidism increases the risk of developing SIBO and whether it changes the types of bacteria in the small intestine. The study analyzed duodenal (upper small intestine) samples from 49 people with hypothyroidism and 323 controls, and separately analyzed 10-year SIBO development rates in large patient databases.
How the Study Was Conducted
This study combined two approaches: analyzing small intestine fluid samples from the REIMAGINE study using DNA sequencing to identify bacteria, and using the TriNetX database to track SIBO diagnosis rates over 10 years in hypothyroid patients compared to matched control groups. Researchers compared bacterial populations between four groups: hypothyroid with SIBO, hypothyroid without SIBO, non-hypothyroid with SIBO, and non-hypothyroid without SIBO. Full methodology not publicly available — summary based on abstract only.
Key Findings
- SIBO was more than twice as common in hypothyroid patients (32.65%) compared to controls (15.17%), with hypothyroid patients showing 2.20 times higher risk and autoimmune thyroiditis patients showing 2.40 times higher risk of developing SIBO over 10 years
- Taking levothyroxine (thyroid replacement medication) appeared to reduce SIBO risk, lowering it to 0.33 times normal in general hypothyroid patients and 0.78 times normal in autoimmune thyroiditis patients
- The types of bacteria differed between groups: Neisseria bacteria were core members only in hypothyroid patients, while Escherichia/Shigella dominated in non-hypothyroid SIBO patients and Klebsiella species were more common in hypothyroid SIBO patients
- Both SIBO groups showed increased Gram-negative coliforms (a family of bacteria including E. coli), but the specific types differed based on thyroid status
Important Limitations
- The hypothyroid group was relatively small (49 participants) compared to controls (323 participants), which may limit statistical power for some comparisons
- The study shows associations between hypothyroidism and SIBO but cannot prove that thyroid problems directly cause bacterial overgrowth — other shared factors could be involved
- Full text not publicly available — summary based on abstract only
Was this summary helpful?
Related Studies
Coming soon: See other studies on similar topics